Navigation Links
New antibiotic already developing resistance

An anti biotic, just a year old, which was developed to fight resistant bacteria, is already becoming stale as the bacteria are showing signs of resistance.

The drug linezolid is used to treat Enterococcus faecium (E. faecium) infections that are resistant to the old standby antibiotic vancomycin. The hope has been that the new drug would help tackle the growing problem of vancomycin-resistant enterococci infections. But in the April 14th issue of The Lancet, Chicago doctors report on five cases in which patients' infections became resistant to linezolid, as well.

Antibiotic resistance is a major problem worldwide, and hospitals are ground zero since infections and antibiotics are part of everyday life in these settings. Bacteria have an innate ability to mutate, and when they are repeatedly exposed to an antibiotic, they learn to change themselves in order to evade the drug. Bacteria that cause diseases such as pneumonia, tuberculosis and meningitis have learned to outsmart standard treatments. Without new drugs, experts fear some bacterial infections will become untreatable.

Before 1989, no US hospitals had experienced vancomycin-resistant E. faecium infections. By 1993, however, more than 10% of these infections acquired in hospitals were resistant to treatment. Linezolid was approved in April 2000 for the treatment of vancomycin-resistant E. faecium. Hence, doctors advice a sensitivity test before starting a patient on linezolid.
'"/>




Page: 1

Related medicine news :

1. Gene clue to antibiotics
2. Excessive use of antibiotics for sore throat
3. E. coli strains resistant to a common antibiotic
4. Cost-effective antibiotics for sinusitis treatment
5. Treatment of antibiotics ineffectual in bronchitis
6. Eczema patients lack natural antibiotic in skin
7. Modified antibiotic may support fight cancer
8. Vaccine Reduces antibiotic-resistant infections in Children
9. Use of antibiotics in farms may increase ‘super bugs
10. Frequent use of antibiotics raises the risk of carrying resistant infections
11. Novel antibiotic dressing developed for improved wound healing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD is dual ... City. He is known for his distinguished expertise and experience in the diagnosis and ... sub-specialty training in treating renovascular disease and aortic aneurysm . He is known ...
(Date:5/24/2017)... Cincinnati, OH (PRWEB) , ... May 24, 2017 , ... ... discreet and comfortable ClearCorrect orthodontics, with or without a referral. Dr. Kejriwal ... is why she offers convenient, clear braces in Cincinnati, OH. Patients no longer need ...
(Date:5/24/2017)... Las Vegas, NV (PRWEB) , ... May 24, ... ... Las Vegas, NV, recently completed Course II of the HP3 (High-Performance Periodontal Practice) ... commits himself to learning the latest advancements in his field by attending numerous ...
(Date:5/24/2017)... ... , ... If you are thinking of a visit to San Francisco , fall is ... perfect time to visit. , Business Architecture Associates is pleased to offer 5 days of ... a 4-½ day package for individuals, and as 4-½ day corporate package for up to ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... label food ingredient solutions for the food and beverage industry offers Citri-Fi®, a ... ingredient statements during the purchasing decision process. As a result, labels need to ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
(Date:5/9/2017)... May 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of ... Canadian Intellectual Property Office has granted Oramed a ... of Exenatide". The patent covers Oramed,s invention of ... GLP-1 is an incretin hormone that stimulates the ...
(Date:5/8/2017)... NEW YORK , May 8, 2017 ... in the transition from fee for service reimbursement. Black ... April 2017. 1.       The Market for ... 77% of physician practices with 3 or ... Compliance Technology Solutions by Q4. "Given the magnitude of ...
Breaking Medicine Technology: